series-b
Stage
3
Investors
About
Akadeum develops GMP-grade microbubble cell separation technology that improves the efficiency, quality, and scalability of therapeutic cell manufacturing for autologous, allogeneic, and next-generation cell therapies.
Explore Akadeum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.